David P Bonita bought $12.5M of Prelude Therapeutics (PRLD)

Executed Apr 21, disclosed Apr 23, 2 days later.

Value, as filed

$12.5M

2,815,315 sh across 2 lots

Executed

Apr 21

the trade date, as filed

Disclosed

Apr 23

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+0.0%

-9.0% from execution

Over the 21 trading sessions from the disclosed entry session (Apr 23), the stock returned +0.0% (delay-adjusted); from the execution session (Apr 21), -9.0%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

DB David P Bonita Director profile →

David P Bonita (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in IMA. Across 1 priced purchase filing, the average 21-session return was -9.0% from execution and +0.0% from disclosure (delay-adjusted; derived). The largest single filing was $12.5M of PRLD (2,815,315 sh across 2 lots, as filed), executed Apr 21.

The name

PRLD PRLD PRLD · 3 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→